Recombinant SARS-CoV-2 Spike RBD, C-mFc

$The purity of SARS-CoV-2 Spike RBD is greater than 95% as determined by SEC-HPLC.\r\n$

$Immobilized SARS-CoV-2 RBD proteins at 0.5ug\/ml (100ul\/Well). Dose response curve for Human ACE2, with the EC50 of 18.7 ng\/ml determined by ELISA.$

Overview
Catalog #	bs-46009p-100ug
Product Name	Recombinant SARS-CoV-2 Spike RBD, C-mFc
Applications	WB, ELISA, HPLC
Reactivity	SARS-CoV-2
Specifications
Conjugation	Unconjugated
Source	Recombinant SARS-CoV-2 Spike RBD, C-mFc protein is expressed in HEK293 with C-mFc. It contains the amino acid sequence of Arg319-Asn532.
Storage Buffer	Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). 5% trehalose is added as a protectant before lyophilization.
Storage Condition	The product should be stored at -70°C or -20°C.
Target
Swiss Prot	QHD43416.1
Background	The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.